Dr. Chaur-Jong Hu is the director of the Dementia Center in Taipei Medical University-Shuang Ho
Hospital, New Taipei City, Taiwan. He is also a professor, vice Dean at the School of Medicine,
College of Medicine, and vice superintendent of Taipei Neuroscience Institute, Taipei Medical University. Dr. Hu obtained his medical degree from Taipei Medical University, Taipei, Taiwan in 1990. He completed Neurology residency training at Taipei Municipal Jen-Ai Hospital. He has also worked
as a research fellow at the Stroke Center, Neurology Department, School of Medicine, Washington
University, St. Louis, Missouri, USA. Dr. Hu is studying the molecular mechanisms of neurological
diseases using of variant animal models, including Alzheimer disease and stroke. Dr Hu has extensive experience in clinical trials of therapies for stroke, Alzheimer Disease and other neurological diseases. He has published over 200 peer-reviewed papers and 2 book chapters on the pathophysiology of ischemic injury of brain and the use of botulinum toxin in neuropathic pain. Dr Hu is currently the President of the Taiwan Neurological Society. He is also a fellow of the American Heart Association (FAHA).
https://hub.tmu.edu.tw/en/persons/chaur-jong-hu
Research Keywords & Expertise
Dementia
Pharmacological treatm...
Preclinical
Disease modifying
Fingerprints
28%
Dementia
5%
Preclinical
5%
Disease modifying
Short Biography
Dr. Chaur-Jong Hu is the director of the Dementia Center in Taipei Medical University-Shuang Ho
Hospital, New Taipei City, Taiwan. He is also a professor, vice Dean at the School of Medicine,
College of Medicine, and vice superintendent of Taipei Neuroscience Institute, Taipei Medical University. Dr. Hu obtained his medical degree from Taipei Medical University, Taipei, Taiwan in 1990. He completed Neurology residency training at Taipei Municipal Jen-Ai Hospital. He has also worked
as a research fellow at the Stroke Center, Neurology Department, School of Medicine, Washington
University, St. Louis, Missouri, USA. Dr. Hu is studying the molecular mechanisms of neurological
diseases using of variant animal models, including Alzheimer disease and stroke. Dr Hu has extensive experience in clinical trials of therapies for stroke, Alzheimer Disease and other neurological diseases. He has published over 200 peer-reviewed papers and 2 book chapters on the pathophysiology of ischemic injury of brain and the use of botulinum toxin in neuropathic pain. Dr Hu is currently the President of the Taiwan Neurological Society. He is also a fellow of the American Heart Association (FAHA).
https://hub.tmu.edu.tw/en/persons/chaur-jong-hu